Am. J. Respir. Crit. Care Med., Volume 162, Number 3, September 2000, 1115-1119

Frequent Genetic Alterations at the Microsatellite Level in Cytologic Sputum Samples of Patients with Idiopathic Pulmonary Fibrosis

DIMITRIS A. VASSILAKIS, GEORGE SOURVINOS, DEMETRIOS A. SPANDIDOS, NIKOLAOS M. SIAFAKAS, and DEMOSTHENES BOUROS

Department of Pneumonology and Laboratory of Virology, Medical School, University of Crete; University Hospital, Heraklion, Greece

Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology associated with DNA damage and malignancy. Bronchogenic carcinoma is the cause of death in 10% to 13% of IPF patients. Microsatellite instability (MSI) and loss of heterozygosity (LOH) are frequently detected in cancers. If these genetic alterations could be observed in IPF, they might explain the higher relative risk of lung cancer in this disease. We investigated the incidence of MSI and LOH in sputum cytologic specimens from 26 IPF patients and 26 healthy, matched subjects, using 10 highly polymorphic microsatellite markers. The electrophoretic pattern of each specimen was compared with that of corresponding peripheral blood. Thirteen (50%) patients showed genetic alterations, consisting either of MSI or LOH. Five (19%) patients exhibited MSI and 10 (39%) exhibited LOH in at least one microsatellite marker. Three (12%) patients showed LOH in more than one marker. None of the healthy subjects exhibited genetic alterations in the studied markers. No correlation was found between the detected genetic alterations and age, disease duration, blood gases, or spirometric parameters of the patients. Our findings suggest that the genetic alterations that we studied are frequent in IPF, are apparently unrelated to the severity of the disease, and may be related to tumorigenesis.

This article has been cited by other articles:

				D. Makris, N. Tzanakis, A. Damianaki, E. Ntaoukakis, E. Neofytou, M. Zervou, N. M. Siafakas, and E. G. Tzortzaki Microsatellite DNA instability and COPD exacerbations Eur. Respir. J., September 1, 2008; 32(3): 612 - 618. [Abstract] [Full Text] [PDF]

				D. A. Schwartz Genetic Analysis of Sporadic and Familial Interstitial Pneumonia Proceedings of the ATS, April 15, 2008; 5(3): 343 - 347. [Abstract] [Full Text] [PDF]

				T. M. Maher, A. U. Wells, and G. J. Laurent Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur. Respir. J., November 1, 2007; 30(5): 835 - 839. [Abstract] [Full Text] [PDF]

				M. I. Zervou, E. G. Tzortzaki, D. Makris, M. Gaga, E. Zervas, E. Economidou, M. Tsoumakidou, N. Tzanakis, J. Milic-Emili, and N. M. Siafakas Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease Eur. Respir. J., September 1, 2006; 28(3): 472 - 478. [Abstract] [Full Text] [PDF]

				A. Cavazza, M. Paci, L. De Marco, G. Leporati, G. Sartori, N. Bigiani, and G. Rossi Alveolar Adenoma of the Lung: A Clinicopathologic, Immunohistochemical, and Molecular Study of an Unusual Case International Journal of Surgical Pathology, April 1, 2004; 12(2): 155 - 159. [Abstract] [PDF]

				E. Paraskakis, G. Sourvinos, F. Passam, N. Tzanakis, E.G. Tzortzaki, M. Zervou, D. Spandidos, and N.M. Siafakas Microsatellite DNA instability and loss of heterozygosity in bronchial asthma Eur. Respir. J., December 1, 2003; 22(6): 951 - 955. [Abstract] [Full Text] [PDF]

				F.R. Hirsch, D.T. Merrick, and W.A. Franklin Role of biomarkers for early detection of lung cancer and chemoprevention Eur. Respir. J., June 1, 2002; 19(6): 1151 - 1158. [Abstract] [Full Text] [PDF]

				D. Bouros, K. Hatzakis, H. Labrakis, and K. Zeibecoglou Association of Malignancy With Diseases Causing Interstitial Pulmonary Changes* Chest, April 1, 2002; 121(4): 1278 - 1289. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1789 - 1804. [Full Text] [PDF]

				G.M. Verleden, R.M. du Bois, D. Bouros, M. Drent, A. Millar, J. Muller-Quernheim, G. Semenzato, S. Johnson, G. Sourvinos, D. Olivieri, et al. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin Eur. Respir. J., July 1, 2001; 18(32_suppl): 17S - 29s. [Abstract] [Full Text] [PDF]